Patient#	Sample#	CD40/CD40L (trimer)/JAK3 (trimer):(CD40/JAK3, active),(CD40L (trimer), active),(Monocyte, active),	C4BPA:(C4BPA, protein),	CBLB:(CBLB, protein),	CD40:(CD40, protein),	FCAMR:(FCAMR, protein),	IL4:(IL4, protein),	MEKK1:(MEKK1, protein),	STAT5A:(CD40/CD40L (trimer)/JAK3 (trimer), active),(STAT5A, protein),	TRAF1:(TRAF1, protein),	TRAF2:(TRAF2, protein),	TRAF6:(TRAF6, protein),	p38alpha-beta:(p38alpha-beta, protein),	C4BPA/CD40:(C4BPA, active),(CD40, active),	CD40/CD40L (trimer):(CD40, active),(CD40L (trimer), active),	STAT5A (dimer):(STAT5A, active),	TTRAP:(TTRAP, protein),	CD40/CD40L (trimer)/TRAF2 (trimer):(B-Lymphocyte, active),(CBLB, active),(CD40/CD40L (trimer), active),(TRAF2, active),(TRAF6, active),(Zn2+, active),	CD40/CD40L (trimer)/TRAF6:(CD40/CD40L (trimer), active),(TRAF6, active),	CD40/CD40L (trimer)/TTRAP:(CD40/CD40L (trimer), active),(TTRAP, active),	TRAF2/CBL-b:(CBLB, active),(CD40/CD40L (trimer), active),(TRAF2, active),	cIAP1/cIAP2/TRAF2:(TRAF2, active),(cIAP1/cIAP2, active),	B cell affinity maturation:(CD40/CD40L (trimer)/TRAF6, active),	CD40/CD40L (trimer)/TRAF2 (trimer)/MEKK1:(CD40/CD40L (trimer)/TRAF2 (trimer), active),(MEKK1, active),	CD40/CD40L (trimer)/TRAF2 (trimer)/TRAF1:(CD40/CD40L (trimer)/TRAF2 (trimer), active),(TRAF1, active),	CD40/CD40L (trimer)/TRAF6/PI3K Class I family/CBL-b:(CD40/CD40L (trimer)/TRAF6, active),(PI3K Class I family/CBL-b, active),	plasma cell differentiation:(CD40/CD40L (trimer)/TRAF6, active),	regulation of germinal center formation:(B-Lymphocyte, active),(CD40/CD40L (trimer)/TRAF2 (trimer), active),	regulation of isotype switching to IgE isotypes:(B-Lymphocyte, active),(CD40/CD40L (trimer)/TRAF2 (trimer), active),(IL4, active),	AKT1:(AKT1, protein),(CD40/CD40L (trimer)/TRAF6/PI3K Class I family/CBL-b, active),	B cell proliferation:(CD40/CD40L (trimer)/TRAF2 (trimer)/MEKK1, active),(FCAMR, active),	CD40/CD40L (trimer)/TRAF2 (trimer)/cIAP1/cIAP2:(CD40/CD40L (trimer)/TRAF2 (trimer), active),(cIAP1/cIAP2, active),	MAP2K4:(CD40/CD40L (trimer)/TRAF2 (trimer)/MEKK1, active),(MAP2K4, protein),	NF kappa B1 p50/RelA/I kappa B alpha:(B-Lymphocyte, active),(C4BPA/CD40, active),(CD40/CD40L (trimer)/TRAF2 (trimer)/TRAF1, active),(CD40/CD40L (trimer)/TRAF6, active),(CD40/CD40L (trimer)/TTRAP, active),	p38alpha-beta-active:(B-Lymphocyte, active),(CD40/CD40L (trimer)/TRAF2 (trimer)/MEKK1, active),(CD40/CD40L (trimer)/TRAF6, active),(p38alpha-beta, active),(p38alpha-beta-active, protein),	regulation of isotype switching to IgG isotypes:(B-Lymphocyte, active),(CD40/CD40L (trimer)/TRAF2 (trimer)/MEKK1, active),(IL4, active),	NFKBIA:(NF kappa B1 p50/RelA/I kappa B alpha, active),(NFKBIA, protein),	RelA/NF kappa B1:(NF kappa B1 p50/RelA/I kappa B alpha, active),	TRAF3:(CD40/CD40L (trimer)/TRAF2 (trimer)/cIAP1/cIAP2, active),(TRAF3, protein),	CD40/CD40L (trimer)/TRAF3 (trimer):(CD40/CD40L (trimer), active),(TRAF3, active),	cIAP1/cIAP2/TRAF2/TRAF3:(TRAF3, active),(cIAP1/cIAP2/TRAF2, active),	proteasomal ubiquitin-dependent protein catabolic process:(B-Lymphocyte, active),(CD40/CD40L (trimer)/TRAF2 (trimer)/TRAF1, active),(NFKBIA, active),(TRAF1, active),(TRAF2/CBL-b, active),(TRAF3, active),	BCL-X(L):(BCL-X(L), protein),	MYC:(MYC, protein),	NIK:(NIK, protein),(cIAP1/cIAP2/TRAF2/TRAF3, active),	TNFAIP3:(TNFAIP3, protein),	degradation:(NIK, active),	JNK family	JNK family-active:(B-Lymphocyte, active),(CD40/CD40L (trimer)/TRAF2 (trimer), active),(JNK family, active),(JNK family-active, protein),(MAP2K4, active),	JUN:(JNK family-active, active),(JUN, protein),	
